Table 1.
Demographics of control and polycystic ovary syndrome patients.
| Variable | PCOS (n = 64) | Control (n = 64) | P value | PCOS-HA (n = 47) | Control (n = 47) | P value | PCOS-NA (n = 17) | Control (n = 17) | P value |
|---|---|---|---|---|---|---|---|---|---|
| Age (y), mean (SD) | 32.2 (3.8) | 32.4 (3.8) | .71 | 32.0 (3.7) | 31.75 (3.7) | .70 | 33.29 (4.1) | 33.29 (3.9) | .95 |
| BMI (kg/m2) mean (SD) | 26.9 (6.5) | 26.2 (5.9) | .53 | 27.44 (6.3) | 26.4 (5.9) | .38 | 25.58 (7.1) | 25.59 (5.7) | .96 |
| Parous, n (%) | 4 (6.5) | 10 (15.9) | .15 | 2 (4.4) | 7 (15.2) | .16 | 2 (12.5) | 3 (17.7) | .99 |
| Tobacco, n (%) | 6 (9.4) | 2 (3.2) | .14 | 6 (12.8) | 1 (2.2) | .10 | 0 (0.0) | 1 (5.9) | .35 |
| AMH (ng/mL) mean (SD) | 8.0 (6.2) | 3.0 (2.2) | <.0001 | 7.77 (6.0) | 3.23 (2.4) | <.0001 | 8.75 (6.9) | 2.50 (1.5) | .0004 |
| Testosterone (ng/dL), mean (SD) | 35.9 (15.3) | 26.5 (12.3) | .08 | 39.07 (15.1) | 23.48 (11.1) | .02 | 24.38 (10.0) | 35.5 (14.8) | .23 |
| Metformin, n (%) | 37 (57.8) | 6 (9.4) | <.0001 | 31 (66.0) | 5 (10.6) | <.0001 | 6 (35.3) | 1 (5.9) | .09 |
Note: Patients are divided by overall cohort and patients with PCOS with HA or those with NA and their corresponding controls. AMH = antimullerian hormone; BMI = body mass index; HA = hyperandrogenemia; NA = normal androgens; PCOS = polycystic ovary syndrome; SD = standard deviation.